菜单 关闭
< 旗帜随机发生器 >
< ===背景色:开始(#00518b) === >

在Lazarex癌症基金会,我们改善病人获得癌症临床试验的机会。

< ===背景色: 结束 === >
< 新闻简报 >

拉扎雷克斯护理

Lazarex关怀计划的重点是改善晚期癌症患者和医疗服务不足者的癌症护理效果,方法是确定FDA临床试验方案,为参与临床试验的自费费用和旅行同伴提供帮助,并促进社区外联和参与。
了解更多

iMPACT

Lazarex IMPACT计划的目标是产生一个可持续的概念证明行动计划,以改变临床试验招募、注册、保留、少数民族参与、完成和转化科学的现状--为所有患者提供公平和及时的癌症发现DeepL。
了解更多

癌症健康中心

Lazarex癌症健康中心为有风险的社区成员提供 "安全空间",以讨论与癌症有关的健康问题,并探索从预防到治疗和临床试验的选择。癌症健康中心被安置在社区内,以管理癌症之旅,并为成功的结果提供最大的机会。
了解更多
< 新闻简报 >

Clinical Trial Chronicles

Our Clinical Trial Chronicles spotlight patient journeys within clinical trial settings. Hear directly from other Lazarex VIPs who have participated in clinical trials and learn about the tools we provide that assist with clinical trial navigation and travel cost reimbursements, to improve cancer health outcomes. So, what exactly is a clinical trial? Gain a deeper understanding about clinical trials and the process through shared patient experiences and educational programs.
阅读更多

Disrupting the System V

On 06.15.22 Lazarex and Medidata hosted some of the biggest disruptors and innovators in oncology, patient advocacy and public policy who are working to make cancer research accessible to all. Through our panel discussions we identify the challenges cancer patients face as they seek to participate in clinical trials in the current climate. Through these discussions we hope to work toward solutions that contribute to improving health outcomes.
现在观看

费城的社区IMPACT和IMPACT

本月早些时候,Dornsife与主要参与者会面,讨论最新的IMPACT计划。十九个人挤在位于春园街的社区资源中心--Dornsife邻里伙伴关系中心的一间会议室里。他们包括宾夕法尼亚州的肿瘤专家、德雷克塞尔大学Dornsife公共卫生学院的教授和默克公司的管理人员,默克公司是这项350万美元计划的资助方。
阅读文章